Natural opening extraction in low rectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial looks back at patients who had surgery for low rectal cancer using a technique where the removed tissue is taken out through a natural opening (like the anus) instead of through a separate cut in the belly. It aims to see how well this approach works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your surgery for low rectal cancer happened between January 2017 and January 2023.
- The cancer was in the lower part of the rectum (as classified by a standard program).
- You had a specific type of surgery called low anterior resection with total mesorectal excision (removing the rectum and nearby tissues).
- You did not have a procedure that removed the rectum without reconnecting the bowel, and you did not have a hand-sewn connection at the anus.
- Your surgery was not planned as open surgery, and it did not need to be converted to open surgery.
- You do not have inflammatory bowel disease (such as Crohn’s disease or ulcerative colitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a strategy to avoid surgery by using watchful waiting after initial treatment for early-stage rectal cancer. It may help patients keep their rectum and avoid a permanent colostomy.
This trial studies removing an early rectal cancer tumor locally (through the rectum/anal area) with no additional therapy afterward. The goal is to preserve organs and maintain quality of life while still trying to cure the cancer.
This trial compares two surgical approaches to remove rectal cancer tissue while aiming to preserve cure chances. It may help you see which approach fits your tumor location and health situation best.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial is testing whether a more limited surgery for mid and low rectal cancer can be safe, by avoiding removal of lymph nodes near the main artery. It may be a good fit if your tumor is in the lower rectum, hasn't spread far, and you are in generally good health.
This trial tests whether a temporary stoma (a bag on the belly) can be safely avoided in some people having rectal cancer surgery. The goal is to see if it's okay to skip the stoma in those with a low risk of complications.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.